Plasmid-based E6-specific siRNA and co-expression of wild-type p53 suppresses the growth of cervical cancer in vitro and in vivo.

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Cancer Letters

• Publication date

  2013-07-10

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.canlet.2013.02.034PMID 23435374PMCID PMC3891667
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The synergistic therapeutic effect of cisplatin with Human papillomavirus E6/E7 short interfering RNA on cervical cancer cell lines in vitro and in vivo

  2012cited by this paper
• Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

  2012cited by this paper
• Inhibition and eradication of human glioma with tumor-targeting Salmonella typhimurium in an orthotopic nude-mouse model

  2012cited by this paper
• Methyl jasmonate reduces the survival of cervical cancer cells and downregulates HPV E6 and E7, and survivin.

  2012cited by this paper
• Withaferin A induces p53-dependent apoptosis by repression of HPV oncogenes and upregulation of tumor suppressor proteins in human cervical cancer cells.

  2011cited by this paper
• Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.

  2011cited by this paper
• Curcumin suppresses human papillomavirus oncoproteins, restores p53, rb, and ptpn13 proteins and inhibits benzo[a]pyrene‐induced upregulation of HPV E7

  2011cited by this paper
• Targeted therapy of spinal cord glioma with a genetically modified Salmonella typhimurium

  2010cited by this paper
• Enhanced tumor suppression in vitro and in vivo by co-expression of survivin-specific siRNA and wild-type p53 protein

  2010cited by this paper
• Vessel destruction by tumor-targeting Salmonella typhimurium A1-R is enhanced by high tumor vascularity

  2010cited by this paper
• Highly potent and specific siRNAs against E6 or E7 genes of HPV16- or HPV18-infected cervical cancers

  2010cited by this paper
• HPV16 E7 oncogene expression in normal human epithelial cells causes molecular changes indicative of an epithelial to mesenchymal transition.

  2009cited by this paper
• Gene silencing of HPV16 E6/E7 induced by promoter-targeting siRNA in SiHa cells

  2009cited by this paper
• BASIC SCIENCE REVIEW

  2007cited by this paper
• Human papillomavirus causes an angiogenic switch in keratinocytes which is sufficient to alter endothelial cell behavior.

  2007cited by this paper
• Human papillomavirus type distribution in invasive cervical cancer and high‐grade cervical lesions: A meta‐analysis update

  2007cited by this paper
• Intratumoral delivery and suppression of prostate tumor growth by attenuated Salmonella enterica serovar typhimurium carrying plasmid-based small interfering RNAs.

  2007cited by this paper
• Human papillomavirus and cervical cancer.

  2007cited by this paper
• Strategies for silencing human disease using RNA interference

  2007cited by this paper
• Monotherapy with a tumor-targeting mutant of Salmonella typhimurium cures orthotopic metastatic mouse models of human prostate cancer

  2007cited by this paper
• Basic mechanisms of high‐risk human papillomavirus‐induced carcinogenesis: Roles of E6 and E7 proteins

  2007cited by this paper
• Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.

  2007cited by this paper
• Induction of cell death in human papillomavirus 18-positive cervical cancer cells by E6 siRNA

  2006cited by this paper
• Systemic Administration of an Attenuated, Tumor-Targeting Salmonella typhimurium to Dogs with Spontaneous Neoplasia: Phase I Evaluation

  2005cited by this paper
• Role of the p53/p21 system in the response of human colon carcinoma cells to Doxorubicin

  2004cited by this paper
• Direct Activation of Bax by p53 Mediates Mitochondrial Membrane Permeabilization and Apoptosis

  2004influential reference
• Human Papillomavirus and Cervical Cancer

  2004cited by this paper
• Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis

  2003cited by this paper
• HPV E6 antisense induces apoptosis in CaSki cells via suppression of E6 splicing

  2002cited by this paper
• The p53 and Mdm2 families in cancer.

  2002cited by this paper
• Chemoradiation of cervical cancer cells: targeting human papillomavirus E6 and p53 leads to either augmented or attenuated apoptosis depending on the platinum carrier ligand.

  2002cited by this paper
• Spatial–temporal imaging of bacterial infection and antibiotic response in intact animals

  2001cited by this paper
• Induction of apoptosis in human papillomaviruspositive cancer cells by peptide aptamers targeting the viral E6 oncoprotein.

  2000cited by this paper
• Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.

  2000cited by this paper
• Activation of p53 in cervical carcinoma cells by small molecules.

  2000cited by this paper
• Biodistribution and genetic stability of the novel antitumor agent VNP20009, a genetically modified strain of Salmonella typhimurium.

  2000cited by this paper
• Clinical implications of p53 mutations

  1999cited by this paper
• Disruption of p53 in human cancer cells alters the responses to therapeutic agents.

  1999cited by this paper
• phoP/phoQ-deleted Salmonella typhi (Ty800) is a safe and immunogenic single-dose typhoid fever vaccine in volunteers.

  1996cited by this paper
• The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.

  1996cited by this paper
• Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53

  1993cited by this paper
• Complex formation of human papillomavirus E7 proteins with the retinoblastoma tumor suppressor gene product.

  1989cited by this paper
• Salmonella typhimurium phoP virulence gene is a transcriptional regulator.

  1989cited by this paper
• A two-component regulatory system (phoP phoQ) controls Salmonella typhimurium virulence.

  1989cited by this paper
• Mutants of Salmonella typhimurium that cannot survive within the macrophage are avirulent.

  1986cited by this paper

• Exploitation of Biocomputational Approaches for siRNA‐Mediated Gene Silencing of HPV: A Novel Therapeutic Strategy for Cervical Cancer

  2025cites this paper
• Small Interfering RNA (siRNA) Based Therapies for Cancer Treatment: A Special Focus on Cervical Cancer.

  2025cites this paper
• Bio-inspired nanoparticles as drug delivery vectors

  2022cites this paper
• A review of PD-1/PD-L1 siRNA delivery systems in immune T cells and cancer cells.

  2022cites this paper
• Emerging Applications of Bacteria as Antitumor Agents.

  2021cites this paper
• Perspectives on Oncolytic Salmonella in Cancer Immunotherapy—A Promising Strategy

  2021cites this paper
• Employing siRNA tool and its delivery platforms in suppressing cisplatin resistance: Approaching to a new era of cancer chemotherapy.

  2021cites this paper
• Unexpected Amplification of Synergistic Gene Expression to Boom Vascular Flow in Advantageous Dual-Gene Co-expression Plasmid Delivery Systems over Physically Mixed Strategy.

  2020cites this paper
• Is viral E6 oncoprotein a viable target? A critical analysis in the context of cervical cancer.

  2020cites this paper
• Therapeutic potential of p53 reactivation in cervical cancer.

  2020cites this paper
• PD-1-siRNA delivered by attenuated Salmonella enhances the antimelanoma effect of pimozide

  2019cites this paper
• Targeting Programmed Fusobacterium nucleatum Fap2 for Colorectal Cancer Therapy

  2019cites this paper
• Therapeutic startegies for human papillomavirus infection and associated cancers.

  2018cites this paper
• Nanoparticles Based on Poly (β-Amino Ester) and HPV16-Targeting CRISPR/shRNA as Potential Drugs for HPV16-Related Cervical Malignancy.

  2018cites this paper
• Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challenges

  2017cites this paper
• Knockdown of HIF-1α by siRNA-expressing plasmid delivered by attenuated Salmonella enhances the antitumor effects of cisplatin on prostate cancer

  2017cites this paper
• Liposome-mediated transfection of wild-type P53 DNA into human prostate cancer cells is improved by low-frequency ultrasound combined with microbubbles.

  2016cites this paper
• Human Papillomavirus E6 Knockdown Restores Adenovirus Mediated-estrogen Response Element Linked p53 Gene Transfer in HeLa Cells.

  2016cites this paper
• Combined RNAi targeting human Stat3 and ADAM9 as gene therapy for non-small cell lung cancer.

  2016cites this paper
• Carcinogenic mechanisms of oncoproteins in high-risk human papillomavirus

  2016cites this paper
• Targeted Cancer Therapy Using Engineered Salmonella typhimurium

  2016cites this paper
• Effect and Safety of Recombinant Adenovirus-p53 Transfer Combined with Radiotherapy on Long-Term Survival of Locally Advanced Cervical Cancer

  2016cites this paper
• MicroRNAs and their Role in the Pathogenesis of Cervical Cancer

  2016cites this paper
• In Vitro and In Vivo Synergistic Therapeutic Effect of Cisplatin with Human Papillomavirus16 E6/E7 CRISPR/Cas9 on Cervical Cancer Cell Line

  2016cites this paper
• Genetically Modified Bacteria as Targeted Agent for Cancer

  2016cites this paper
• HPV E6 Knockdown Restores Adenovirus Mediated-Estrogen Response Element Linked p53 Gene Transfer in HeLa Cells

  2016cites this paper
• Human Papillomavirus: Current and Future RNAi Therapeutic Strategies for Cervical Cancer

  2015cites this paper
• Synergistic effects of eukaryotic co-expression plasmid-based STAT3-specific siRNA and LKB1 on ovarian cancer in vitro and in vivo.

  2015cites this paper
• Additive effects of eukaryotic co-expression plasmid carrying GRIM-19 and LKB1 genes on breast cancer in vitro and in vivo

  2015cites this paper
• Prospects of molecularly-targeted therapies for cervical cancer treatment.

  2015cites this paper
• Synergistic effects of co-expression plasmid‑based ADAM10-specific siRNA and GRIM-19 on hepatocellular carcinoma in vitro and in vivo.

  2014cites this paper
• microRNA expression and function in virus-associated human cancers

  2013cites this paper